ES2056889T3 - Derivados de triazoldiacepina. - Google Patents
Derivados de triazoldiacepina.Info
- Publication number
- ES2056889T3 ES2056889T3 ES88121165T ES88121165T ES2056889T3 ES 2056889 T3 ES2056889 T3 ES 2056889T3 ES 88121165 T ES88121165 T ES 88121165T ES 88121165 T ES88121165 T ES 88121165T ES 2056889 T3 ES2056889 T3 ES 2056889T3
- Authority
- ES
- Spain
- Prior art keywords
- alcoxy
- integer
- alkyl
- chain
- short
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
NUEVOS COMPUESTOS DE FORMULA(I), EN LA QUE X ES - CH = CH - O S, R1 ES ALQUILO O ALCOXI DE CADENA CORTA O - CF3, R2 ES H, ALQUILO, ALCOXI O ALCANOILOXI DE CADENA CORTA OH, R3 Y R4 SON INDEPENDIENTEMENTE H, CL, F, ALQUILO O ALCOXI DE CADENA CORTA, R5 ES UN RADICAL DE FORMULA R6 - (CH2)N - C = C - O R7 - O - (CH2)M - C = C - (R6 Y R7 SON ARILO O UN RADICAL HETEROCICLICO, N ES UN ENTERO DE 0 A 2, Y M ES UN ENTERO DE 1 A 2), S ES UN ENTERO DE 0 A 1, CON LA CONDICION DE QUE CUANDO S ES 1 R2 NO ES H, ALCOXI O ALCANOILOXI, QUE CUANDO N ES 0, R6 DEBE ESTAR UNIDO A TRAVES DE UN ENLACE C - C, Y QUE R7 ESTE SIEMPRE UNIDO A TRAVES DE UN ENLACE C - O, Y CUIANDO HAY AL MENOS UN CENTRO ASIMETRICO, SUS ENANTIOMEROS Y RACEMATOS Y SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES, MUESTRAN ACTIVIDAD COMO ANTAGONISTAS DEL FACTOR ACTIVADOR DE PLAQUETAS Y SON POR ELLO UTILES EN ESTADOS PATOLOGICOS CARACTERIZADOS POR EXCESO DE FACTOR ACTIVADOR DE PLAQUETAS O PARA LA PREVENCION Y TRATAMIENTO DE NEFERMEDADESCARDIOVASCULARES, PULMONARES INMUNOLOGICAS, INFLAMATORIAS, DERMATOLOGICAS, ESTADOS DE SHOCK O RECHAZOS DE TRASPLANTES.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13472687A | 1987-12-18 | 1987-12-18 | |
| US22794888A | 1988-08-03 | 1988-08-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2056889T3 true ES2056889T3 (es) | 1994-10-16 |
Family
ID=26832617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES88121165T Expired - Lifetime ES2056889T3 (es) | 1987-12-18 | 1988-12-16 | Derivados de triazoldiacepina. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0320992B1 (es) |
| JP (1) | JPH0725762B2 (es) |
| KR (1) | KR890009932A (es) |
| CN (1) | CN1031057C (es) |
| AT (1) | ATE109148T1 (es) |
| AU (1) | AU612441B2 (es) |
| CA (1) | CA1327570C (es) |
| CS (1) | CS833288A2 (es) |
| DE (1) | DE3850866T2 (es) |
| DK (1) | DK704088A (es) |
| ES (1) | ES2056889T3 (es) |
| FI (1) | FI88799C (es) |
| HU (1) | HU204273B (es) |
| IE (1) | IE63762B1 (es) |
| IL (1) | IL88688A0 (es) |
| MC (1) | MC1999A1 (es) |
| NO (1) | NO167920C (es) |
| NZ (1) | NZ227341A (es) |
| PT (1) | PT89250B (es) |
| RU (1) | RU2094436C1 (es) |
| YU (1) | YU46991B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH30676A (en) * | 1986-07-22 | 1997-09-16 | Boehringer Ingelhein Kg | Hetrazepine compounds which have useful pharmaceutical utility |
| JP2959598B2 (ja) * | 1990-10-12 | 1999-10-06 | 吉富製薬株式会社 | 光学活性なチエノトリアゾロジアゼピン化合物 |
| US5130315A (en) * | 1991-01-10 | 1992-07-14 | Raymond R. Wittekind | 1-piperazinyl-2-butenes and -2-butynes |
| WO1994006802A1 (fr) * | 1992-09-18 | 1994-03-31 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose de thienodiazepine et son utilisation medicinale |
| US5302590A (en) * | 1992-12-18 | 1994-04-12 | Hoffmann-La Roche Inc. | Compounds useful as dual antagonists of platelet activating factor and leukotriene D4 |
| DE19839566C2 (de) * | 1998-08-31 | 2002-01-17 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten in der Transplantationsmedizin |
| EP1925614A1 (en) * | 2002-03-28 | 2008-05-28 | Wisys Technology Foundation, Inc. | Anxiolytic agents with reduced sedative and ataxic effects |
| DE60319812T2 (de) * | 2002-03-28 | 2009-04-23 | Wisys Technology Foundation, Inc., Madison | Angstlösende wirkstoffe mit verminderten beruhigenden und ataktischen nebenwirkungen |
| US7618958B2 (en) | 2004-06-30 | 2009-11-17 | Wisys Technology Foundation, Inc. | Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| BRPI0513811A (pt) * | 2004-07-27 | 2008-07-15 | Gilead Sciences Inc | imidazo [4,5-d] pirimidinas, seus usos e processos de preparação |
| CN101014345A (zh) * | 2004-09-09 | 2007-08-08 | 默克公司 | 三环酰苯胺螺环内酰胺cgrp受体拮抗剂 |
| US7750010B2 (en) * | 2004-09-13 | 2010-07-06 | Merck Sharp & Dohme Corp. | Tricyclic anilide spirohydantion CGRP receptor antagonists |
| KR100858262B1 (ko) * | 2004-10-13 | 2008-09-11 | 에프. 호프만-라 로슈 아게 | Ｃｄｋ2 및 혈관신생에 대한 저해제로서 유용하고, 유방암,대장암, 폐암 및 전립선암의 치료용으로 유용한이중치환된 피라졸로벤조디아제핀 |
| JP5844358B2 (ja) * | 2010-06-22 | 2016-01-13 | グラクソスミスクライン エルエルシー | ベンゾトリアゾロジアゼピン化合物を含むブロモドメイン阻害剤 |
| WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| US9422292B2 (en) | 2011-05-04 | 2016-08-23 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| UA110640C2 (uk) | 2011-05-05 | 2016-01-25 | Янссен Фармацевтика Нв | ПРОТИГРИБКОВІ 5,6-ДИГІДРО-4Н-ПІРОЛО[1,2-a][1,4]БЕНЗОДІАЗЕПІНИ ТА 6Н-ПІРОЛО[1,2-a][1,4]БЕНЗОДІАЗЕПІНИ, ЯКІ ЗАМІЩЕНІ ГЕТЕРОЦИКЛІЧНИМИ ПОХІДНИМИ |
| WO2012174487A2 (en) | 2011-06-17 | 2012-12-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US9624244B2 (en) | 2012-06-06 | 2017-04-18 | Constellation Pharmaceuticals, Inc. | Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| CN105492428A (zh) * | 2013-05-01 | 2016-04-13 | 中央研究院 | 治疗β-地中海贫血和镰状细胞病的方法和组合物 |
| CN103694253A (zh) * | 2013-11-04 | 2014-04-02 | 湖南华腾制药有限公司 | 一种噻吩并三唑并[4,3-a][1,4]二氮杂卓类化合物的制备方法 |
| PL3157928T3 (pl) | 2014-06-20 | 2019-07-31 | Constellation Pharmaceuticals, Inc. | Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu |
| WO2018083051A1 (en) * | 2016-11-01 | 2018-05-11 | F. Hoffmann-La Roche Ag | 1,3-dihydro-1,4-benzodiazepine-2-thiones for the treatment of cns related diseases |
| CA3200710A1 (en) * | 2020-11-16 | 2022-05-19 | Boehringer Ingelheim International Gmbh | Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3435973A1 (de) * | 1984-10-01 | 1986-04-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung |
| DE3778559D1 (de) * | 1986-01-21 | 1992-06-04 | Boehringer Ingelheim Kg | Thieno-1,4-diazepine. |
| DE3610848A1 (de) * | 1986-04-01 | 1987-10-15 | Boehringer Ingelheim Kg | Neue 1,4-diazepine |
| EP0315698B1 (en) * | 1987-05-28 | 1993-03-03 | Yoshitomi Pharmaceutical Industries, Ltd. | Thieno(triazolo)diazepine compounds and medicinal application of the same |
-
1988
- 1988-12-06 MC MC882021A patent/MC1999A1/fr unknown
- 1988-12-15 IL IL88688A patent/IL88688A0/xx unknown
- 1988-12-15 CA CA000585981A patent/CA1327570C/en not_active Expired - Fee Related
- 1988-12-15 NZ NZ227341A patent/NZ227341A/en unknown
- 1988-12-15 CS CS888332A patent/CS833288A2/cs unknown
- 1988-12-16 HU HU886449A patent/HU204273B/hu not_active IP Right Cessation
- 1988-12-16 FI FI885820A patent/FI88799C/fi not_active IP Right Cessation
- 1988-12-16 AU AU26989/88A patent/AU612441B2/en not_active Ceased
- 1988-12-16 NO NO885597A patent/NO167920C/no unknown
- 1988-12-16 JP JP63316555A patent/JPH0725762B2/ja not_active Expired - Lifetime
- 1988-12-16 PT PT89250A patent/PT89250B/pt not_active IP Right Cessation
- 1988-12-16 YU YU228088A patent/YU46991B/sh unknown
- 1988-12-16 DK DK704088A patent/DK704088A/da not_active Application Discontinuation
- 1988-12-16 ES ES88121165T patent/ES2056889T3/es not_active Expired - Lifetime
- 1988-12-16 AT AT88121165T patent/ATE109148T1/de not_active IP Right Cessation
- 1988-12-16 EP EP88121165A patent/EP0320992B1/en not_active Expired - Lifetime
- 1988-12-16 IE IE375888A patent/IE63762B1/en not_active IP Right Cessation
- 1988-12-16 DE DE3850866T patent/DE3850866T2/de not_active Expired - Fee Related
- 1988-12-17 KR KR1019880016887A patent/KR890009932A/ko not_active Ceased
- 1988-12-17 CN CN88108697A patent/CN1031057C/zh not_active Expired - Fee Related
-
1992
- 1992-01-31 RU SU925010684A patent/RU2094436C1/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2056889T3 (es) | Derivados de triazoldiacepina. | |
| ES2059489T3 (es) | Derivados bencimidazol 1-alkil sustituidos. | |
| MY100740A (en) | Spiro-substituted glutaramide diuretic agents. | |
| FI810389L (fi) | Foerfarande foer framstaellning av substituerade imidazolderivat | |
| GB1107470A (en) | Basic esters and a process for their production | |
| YU45598B (sh) | Bis-(piperazinil)-oz homopiperazinil)-alkani | |
| ES2068497T3 (es) | Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen. | |
| ES374291A1 (es) | Un procedimiento para la preparacion de compuestos de 6,7- diaciloxi-tetrahidroisoquinoleinas. | |
| AR240812A2 (es) | Compuestos derivados de acido tioxo-2-imidazolinilbenzoico, composicion que los comprende y procedimientos para producirlos. | |
| FI900650A0 (fi) | Kalciumantagonister. | |
| GB1124261A (en) | Naphthofuran derivatives | |
| US3974192A (en) | 16-Fluoro prostaglandin B1 analogs | |
| US3974189A (en) | 16-Fluoro prostaglandin E2 analogs | |
| SE7407129L (es) | ||
| AR245696A1 (es) | Derivados del acido (7-(hetero)ariloxi-naftalin-2-il-oxi)-alcancarboxilico | |
| ES8602086A1 (es) | Un procedimiento para preparar y estabilizar una suspension acuosa transportable y bombeable de una zeolita pulverulenta del tipo a. | |
| ES379494A1 (es) | Un procedimiento de preparar nuevos compuestos de sulfoni- lurea o de sus sales. | |
| ES2077743T3 (es) | Derivados amida de acido piridinocarboxilico y composiciones farmaceuticas que los comprenden. | |
| NO119799B (es) | ||
| GB1282405A (en) | Piperidine spiro compounds and pharmaceutical preparations thereof | |
| GB1184395A (en) | Substituted Piperazine Derivatives | |
| JPS57108016A (en) | Antithrombotic agent | |
| ES270093A1 (es) | Procedimiento de obtenciën de nuevos homotiaxantenos | |
| IT1056706B (it) | Procedimento per la preparazione di 1,oxo iscindoline 2,3 sostituite | |
| GB1074435A (en) | Improvements in or relating to substituted diazaspirodecandiones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 320992 Country of ref document: ES |